Stage determination and therapeutic decision in human African trypanosomiasis: Value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire

Tropical Medicine and International Health

Volumn 8, Issue 7, 2003, Pages 589-594

  Jamonneau, V ^a   Solano, Philippe ^a   Garcia, A ^b   Lejon, V ^c   Dje N ^d   Miezan, T W ^d   N'Guessan, P ^a   Cuny, G ^e   Buscher P ^c  

^a Institut Pierre Richet Bouake   (Côte d’Ivoire)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Proj Rech Cliniques Trypanosomiase   (Côte d’Ivoire)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Cerebrospinal fluid; C te d'Ivoire; Diagnosis; Human African trypanosomiasis; Immunoglobulin M; Polymerase chain reaction

Indexed keywords

DNA; IMMUNOGLOBULIN M; PENTAMIDINE;

HEALTH MONITORING; MONITORING SYSTEM; POLYMERASE CHAIN REACTION; TRYPANOSOMIASIS;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENCEPHALITIS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LATEX AGGLUTINATION TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MENINGITIS; NONHUMAN; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; HUMANS; IMMUNOGLOBULIN M; LATEX FIXATION TESTS; LEUKOCYTE COUNT; PATIENT SELECTION; PENTAMIDINE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

COTE D'IVOIRE;

PROTOZOA;

EID: 0037898326     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01079.x     Document Type: Article

References (26)

1. Bisser S, Bouteille B, Sarda J et al. (1997) Apport des examens biochimiques dans le diagnostic de la phase nerveuse de la Trypanosomose humaine africaine. Bulletin de la Société de Pathologie Exotique 90, 321-326.
2. Blum J, Nkunku S & Burri C (2001) Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomosis. Tropical Medicine and International Health 6, 390-400.
3. Bouteille B, Millet P, Enanga B et al. (1998) Human African trypanosomosis, contribution to experimental models. Bulletin de la Société de Pathologie Exotique, 91, 127-132.
4. Bronner U, Doua F, Ericsson O et al. (1991) Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 608-611.
5. Cattand P, Miezan TW & de Raadt P (1988) Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bulletin of the World Health Organization 66, 83-86.
6. Doua F, Miezan TW, Sanon Singaro JR, Boa Yapo F & Baltz T (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. American Journal of Tropical Medicine and Hygiene 55, 586-588.
7. Garcia A, Jamonneau V, Magnus E et al. (2000) Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population. Tropical Medicine and International Health 5, 786-793.
8. Jamonneau V, Garcia A, N'Guessan P et al. (2000) Clinical and biological evolution of human African trypanosomiasis in Côte d'Ivoire. Annals of Tropical Medicine & Parasitology 94, 831-835.
9. Kabiri M, Franco JR, Simarro PP, Ruiz JA, Sarsa M & Steverding D (1999) Detection of Trypanosoma brucei gambiense in sleeping sickness suspects by PCR amplification of expression-site-associated genes 6 and 7. Tropical Medicine and International Health 10, 658-661.
10. Kyambadde JW, Enyaru JCK, Matovu E, Odiit M & Carasco JF (2000) Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bulletin of the World Health Organization 78, 119-124.
11. Lejon V & Büscher P (2001) Stage determination and follow-up in sleeping sickness. Médecine Tropicale 61, 355-360.
12. Lejon V, Büscher P, Sema P, Magnus E & Van Meirvenne N (1998) Human African trypanosomiasis: a LATEX agglutination field test for quantifying IgM in cerebrospinal fluid. Bulletin of the World Health Organization 76, 553-558.
13. Lejon V, Legros D, Richer M et al. (2002) IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Tropical Medicine and International Health 7, 685-692.
14. Mattern P (1968) Etats actuel et résultats des techniques immunologiques utilisées à l'Institut Pasteur de Dakar pour le diagnostic et l'étude de la trypanosomiase humaine africaine. Bulletin of the World Health Organization 38, 1-8.
15. Miezan TW, Bronner U, Doua F, Cattand C & Rombo L (1994) Long-term exposure of Trypanosoma brucei gambiense to pentamidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 332-333.
16. Miezan TW, Meda HA, Doua F, Djé NN, Lejon V & Büscher P (2000) Simple centrifugation of cerebrospinal fluid in a sealed Pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 293.
17. Moser DR, Cook GA, Ochs DE, Bailey CP, McKane MR & Donelson JE (1989) Detection of Trypanosoma congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase chain reaction. Parasitology 99, 57-66.
18. Penchenier L, Dumas V, Grébaut P, Reifenberg JM & Cuny G (1996) Improvement of blood and fly gut processing for PCR diagnosis of trypanosomiasis. Parasite 4, 387-389.
19. Pentreath VW & Owolabi AO (1992) Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Annals of Tropical Medicine and Parasitology 86, 29-34.
20. Pepin J & Milord F (1994) The treatment of human African trypanosomiasis. Advances in Parasitology 33, 1-47.
21. Solano PV, Jamonneau P, Nguessan L et al. (2002) Comparison of different DNA preparation protocols for PCR diagnosis of human African trypanosomosis in Côte d'Ivoire. Acta tropica 82, 349-356.
22. Truc P, Jamonneau V, N'Guessan P, N'Dri L, Diallo PB & Cuny G (1998) A mixed infection in man with Trypanosoma brucei spp. and Trypanosoma congolense in Cöte d'Ivoire: a case report. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 537-538.
23. Truc P, Jamonneau V, Cuny G & Frezil JL (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bulletin of the World Health Organization 77, 745-749.
24. WHO (1986) Epidemiology and Control of African Trypanosomiasis. Technical Report Series 739. World Health Organization, Geneva.
25. WHO (1998) Control and surveillance of African trypanosomiasis. Technical Report Series 881. World Health Organization, Geneva.
26. Walsh PS, Metzger DA & Higuchi R (1991) Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10, 506-513.